The Clinico-epidemiologic Characteristics of Iraqi Patients with Neuroendocrine Tumors and Their Response to Long Acting Octreotide
Background: The lack of studies regarding the neuroendocrine tumors (NET) is related to the rarity of these tumors .Long acting Octreotide is an established treatment for NETs by both providing symptomatic relief & inhibiting tumor growth. However, studies regarding incidence of NETs & their...
Main Authors: | Marwah K. Abdulfattah, Manwer A. Al-naqqash |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2016-01-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/271 |
Similar Items
-
Chromogranin A: As A Tumor Marker for Neuroendocrine Tumors Diagnosis, Follow-up & Its Correlation with Response to Somatostatin Analogues
by: Manwar A. Mohammed AL-Naqqash
Published: (2016-01-01) -
Sandostatin i Sandostatin LAR pri metabolicheskikh, neyroendokrinnykh i onkologicheskikh zabolevaniyakh
by: E A Pigarova, et al.
Published: (2011-03-01) -
Neuroendocrine tumors: Laboratory diagnosis
by: Tzontcheva Anna
Published: (2010-01-01) -
Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
by: Yau H, et al.
Published: (2017-12-01) -
Changes in exocrine and endocrine secretion of the pancreas in the treatment of chronic pancreatitis of alcoholic etiology with somatostatin analogue
by: L V Vinokurova, et al.
Published: (2003-02-01)